Thus, it is possible that patients with MS or T2D may have reduced AMPK phosphorylation levels (in PMBCs) compared to healthy people, and GLP-1 RA could increase AMPK phosphorylation levels. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.